Sign in
HROW Stock Price, Chart, Stats & News
Harrow Health, Inc.
Save
1.59B
Market cap
213.40x
Current P/E
285.71x
Forward P/E
HROW chart
1M
3M
1Y
5Y
Loading chart...
Fundamentals
Gross margin | 75.05% |
Operating margin | 11.21% |
Pretax margin | -3.27% |
Net margin | -1.89% |
Effective tax rate | 42.32% |
ROA | -1.29% |
ROE | -10.00% |
D/E | 4.80x |
Interest coverage ratio | 1.26x |
HROW valuation
P/E | 213.40x |
P/S | 4.63x |
P/B | 23.71x |
P/CF | 28.35x |
P/FCF | 29.33x |
P/OCF | 28.35x |
PEG | 33.88x |
EV multiple | 28.37x |
About
Harrow Health, Inc. operates as a healthcare enterprise with a specialized focus on ophthalmic solutions. The company's portfolio includes ImprimisRx, a business dedicated to ophthalmology outsourcing and pharmaceutical compounding, as well as DEXYCU, a product utilized for managing post-operative inflammation. Beyond its direct offerings, Harrow Health maintains equity investments in several pharmaceutical ventures.
Similar securities
Based on sector and market capitalization
Report issue